Tata Capital backed Cellcure Cancer Centre Private Limited (Mumbai Oncocare Centre) has raised $18 million from Elevation Capital.

Pioneer Legal advised Tata Capital on this transaction.

The transaction team consisted of Anupam Shukla (Partner), Pavana Padmakumar (Principal Associate) and Krishna Bhatia (Associate).

AZB & Partners advised Mumbai Oncocare Centre on this fundraise.

Shardul Amarchand Mangaldas & Co advised the investor Elevation Capital on this transaction.

This financial boost will fuel the company's expansion, enabling it to open new centers and broaden its service offerings, particularly in the daycare oncology space, with a strong focus on chemotherapy and medical management. MOC has demonstrated significant growth, having previously raised $10 million from Tata Capital Healthcare Fund in 2023, and through a recent collaboration with Hemato Oncology Clinic (HOC) to extend its reach in Gujarat.

Cellcure Cancer Centre Private Limited operates well-known cancer daycare centers in Mumbai under the brand Mumbai Oncocare Centre.

MOC is a community cancer centre that provides excellent Oncology & Hematology healthcare services to patients. MOC offers best-in-class and most updated medical interventions, highly qualified doctors in cancer treatment and related services using a State-of-the-Art facility coupled with seamless healthcare services for patients.

Last year, MOC had merged Hemato Oncology Clinic (Ahmedabad).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.